Investment Analysis of Regeneron Pharmaceuticals Inc (REGN)
Investment Thesis Buy
Investment Criteria
Anticipated Hold Period:
Medium-term (1-3 years)
Investment Amount
$833
Decision
Buy
Conviction Level
Low - Took a flyer on this division. Worst case, we shut it down and blame the interns.
Your Share of Net Income
$61.50
Competitive Analysis
Competitive Advantage
No competitive advantage analysis provided.
Key Non-Financial Metrics
No key metrics provided.
Net Income Projections
Net Income
CAGR: 20.8%Analyst Notes:
No comments provided by the analyst.
Dividends
Analyst Notes:
No comments provided by the analyst.
Payout Ratio
Analyst Notes:
No comments provided by the analyst.
Revenue
CAGR: 12.7%Analyst Notes:
No comments provided by the analyst.
Avg Annual Growth Rate (10Y)
Analyst Notes:
No comments provided about CAGR comparison.
Balance Sheet Cash
CAGR: 14.8%Analyst Notes:
No comments provided by the analyst.
Debt
CAGR: 17.9%Analyst Notes:
No comments provided by the analyst.
Free Cash Flow
CAGR: 18.4%Analyst Notes:
No comments provided by the analyst.
Cash Flow from Operations
CAGR: 12.2%Analyst Notes:
No comments provided by the analyst.
0 Comments
No comments yet. Be the first to comment!